• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Human Fibrinogen
    3 Drugs classified under this active ingredient

    All the Active Ingredient Drugs

    Haemocomplettan P
    not in the basket chart
    Haemocomplettan P

    Human Fibrinogen 1 g/vial, 2 g/vial.
    VIAL (pwdr. for inject./IV infus.): 1 x 1 g, 2 g.
    Inject./infus. rate not to exceed
    approx. 5 ml/min. See lit.
    Acute bleed. episodes in congen. fibrinogen
    defic., incl. afibrinogenem.,
    hypofibrinogenem. Not for
    C/I: Hypersens., manifest. thrombos.,
    myocard. infarct. except in life threaten.

    not in the basket chart
    Multiple ingredients

    Human Fibrinogen 5.5 mg, Human Thrombin 2 IU.
    MEDICATED SPONGE: 1 x 9.5 cm x 4.8
    cm; 3.0 cm x 2.5 cm; 2 x 4.8 cm x 4.8 cm;
    5 x 3.0 cm x 2.5 cm. Accord. to clin.
    need and size of wound. See lit.
    Support. tmt. in surg. for improve.
    hemostatis to promote tissue seal, suture
    support in vascular surg. where standard
    technique insuffic.

    not in the basket chart
    Multiple ingredients

    Local Hemostatics. Aprotinin (acetate) 3000 KIU / 1 ml, Calcium Chloride Dihydrate 40 mcmol/ml, Human Fibrinogen 91 mg / 1 ml, Human Thrombin 500 IU / 1 ml.
    PRE-FILL. SYR.: 2, 4 ,10 mL. Applied. as a thin layer by dripp. or spray. using cannula or spray set. Ensure that the amount of the agento be applied is suffic. to entirely cover the intended application area. See lit.
    Supportive tmt. in adult. & child. from 1 mnth. of age where standard surg. techniq. appear insufficient: For improv. of Hemostasis. As a tissue glue to improve wound healing or to support sutures in vascular surgery and in GI anastomoses. For tissue sealing, to improve adhesion of the separated tissue (e.g. tissue flaps, grafts, split skin grafts [mesh grafts]). Efficacy in fully heparinized pts. has been proven.
    C/I: Not for inject. to the circulat. syst. or into highly vascularized tissue. Known hypersens. to aprotinin. Do not use for the tmt. of severe or brisk arterial/venous bleed.
    The spray should be applied with the min. recomm. distance from the applicator tip to the target site cannot be assured.